Futures Market: The overnight session of the most-traded alumina 2509 futures contract opened at 2,976 yuan/mt, with a high of 2,981 yuan/mt, a low of 2,941 yuan/mt, and closed at 2,944 yuan/mt, down ...

Global caustic soda market to reach 95.7 million tons by 2033, driven by steady demand across key industries at a CAGR of 1.41%. NEW YORK, NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- ...

It will extract alumina and produce cement directly from common silicate rocks rich in alumina and calcium from the local Roosevelt quarry using Brimstone's patented Rock Refinery™ process, replacing ...

Abstract Bauxite residue (BR), a by-product of alumina and aluminum production, consists of high aluminum, silica, and iron content, and sodium from the bauxite ore digestion during the Bayer process.

California-based Brimstone is teaming up with OKC-based Dolese Bros. to use its Roosevelt quarry to produce alumina for ...

With Nubeqa and kidney disease treatment Kerendia—which achieved an 89% increase in sales to 161 million euros ($179 million) in the first quarter—Bayer has a pair of fast-rising drugs that ...

For years, Bayer AG was one of Germany’s worst-performing stocks. Now, it’s turning out to be among the biggest gainers. The pharma and chemical conglomerate soared some 40% in 2025, ranking ...

Bayer wanted Missouri to protect it from Roundup lawsuits. The bill failed — but it may return St. Louis Public Radio | By Evy Lewis Published June 5, 2025 at 4:00 AM CDT Listen • 3:48 ...

Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation ...

A history of BayerBayer has been around for more than 150 years, and has continued to evolve throughout its long history Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in ...

Investing.com -- Shares of Bayer AG (ETR: BAYGN) were up over 5% on Thursday after Goldman Sachs upgraded the German pharmaceutical and life sciences company to a "buy" rating from "neutral." ...